CSIMarket
 
Steris Plc  (NYSE: STE)
Other Ticker:  
 

Select the Financial Report: Select the Period:


Description of Steris Plc's Business Segments


Steris Plc stands out as a leading provider of healthcare products, services, and technologies dedicated to enhancing patient safety and improving operational performance across healthcare institutions. The companys comprehensive offerings are categorized into three primary segments: Healthcare Products, Life Sciences Products, and Healthcare Specialty Services. Each segment features an extensive variety of tailored solutions designed to meet the unique demands of healthcare facilities.

1. Healthcare Products

The Healthcare Products segment is essential, offering a broad spectrum of items targeting both critical and non-critical areas in healthcare environments. Key offerings include:

- Surgical Equipment: Steris has developed a diverse range of surgical instruments and devices crucial for various types of surgical procedures. This category encompasses a multitude of tools, including suturing devices, retractors, and electrosurgical units, all of which are designed to enhance the efficacy and safety of surgical interventions. The company emphasizes ergonomic design and reliable performance to support surgeons in delivering optimal outcomes.

- Sterilization Systems: At the core of Steriss commitment to patient safety lies its advanced sterilization technologies. These include steam sterilization, ethylene oxide sterilization, and hydrogen peroxide gaseous plasma technology. Each system is engineered to ensure that medical instruments and equipment are thoroughly sanitized, effectively eliminating harmful microorganisms and thereby facilitating safe surgical environments.

- Infection Prevention Products: The company offers a wide array of infection control products, including antiseptics, disinfectants, and personal protective equipment (PPE). These vital components are integral in reducing the risk of healthcare-associated infections (HAIs), ensuring a safer environment for both healthcare professionals and patients.

- Instrument Tracking and Management Systems: Steris provides innovative tracking solutions that assist healthcare facilities in managing surgical instruments throughout their lifecycle. These systems feature RFID technology and software solutions that allow for real-time tracking of instrument location, usage history, and sterilization status. By improving instrument accountability and operational efficiency, these systems help healthcare organizations maintain compliance with safety standards.

Life Sciences Products

The Life Sciences Products segment is designed to support the rigorous demands of the pharmaceutical and biotechnology sectors, emphasizing research, development, and manufacturing processes. Key offerings include:

- Laboratory Equipment: Steris produces a range of laboratory equipment critical for research and diagnostics. This includes incubators, centrifuges, autoclaves, and biosafety cabinets, all designed to ensure accuracy and safety in laboratory operations. Each product aligns with high industry standards, promoting integrity in experimental results.

- Cleanroom Systems: Steris specializes in designing and constructing cleanroom environments adhering to strict regulatory guidelines essential for pharmaceutical manufacturing. Their cleanroom technology ensures controlled contamination levels, thus providing an optimal environment for the production of sterile products and biotechnological innovations.

- Microbial Reduction Products: This includes an extensive portfolio of sterilants and cleaning agents specifically engineered for laboratory settings. These products play a crucial role in achieving microbial reduction and ensuring that laboratory and manufacturing activities comply with stringent regulatory standards.

Healthcare Specialty Services

In addition to its product offerings, Steris provides specialized services aimed at enhancing operational efficiency and ensuring patient safety within healthcare institutions. Services available include:

- Surgical Instrument Repair: Steris offers professional repair and maintenance services for surgical instruments, allowing healthcare facilities to prolong the lifespan of their tools and uphold the highest safety and performance standards. This service not only provides cost savings by reducing the need for new purchases but also enhances the reliability of surgical instruments.

- Equipment Leasing: Steris facilitates healthcare institutions with leasing options for a diverse array of medical and laboratory equipment. This service allows organizations to access cutting-edge technology without the burden of significant upfront costs, thereby helping to manage budgets more effectively while ensuring operational flexibility.

- Technical Training and Support Services: Steris is committed to providing comprehensive training programs and ongoing technical support for healthcare personnel. These initiatives ensure users are well-versed in the safe operation and maintenance of Steris products, ultimately improving overall operational efficiency and patient safety through knowledgeable and prepared staff.

Commitment to Innovation and Safety

Steris Plcs expansive portfolio reflects its unwavering commitment to delivering innovative, high-quality products and services tailored to the evolving needs of healthcare settings. By integrating state-of-the-art technologies and expert services, Steris endeavors to empower healthcare institutions to enhance patient care, improve operational efficiencies, and reduce overall costs. This holistic approach positions Steris as an invaluable partner for healthcare facilities striving for excellence in patient safety and operational performance.

 

Composition of Steris Plc Revenues by Segments

 
IRELAND    1.76 % of total Revenue
UNITED STATES    73.15 % of total Revenue
Other foreign locations    25.09 % of total Revenue
Healthcare    71.21 % of total Revenue
Healthcare Capital equipment revenues    18.59 % of total Revenue
Healthcare Consumable revenues    26.14 % of total Revenue
Healthcare Sales Revenue Services Net    26.49 % of total Revenue
Applied Sterilization Technologies    18.83 % of total Revenue
Applied Sterilization Technologies Capital equipment revenues    0.37 % of total Revenue
Applied Sterilization Technologies Sales Revenue Services Net    18.47 % of total Revenue
Life Science Member    9.95 % of total Revenue
Life Science Member Capital equipment revenues    2.27 % of total Revenue
Life Science Member Consumable revenues    5.01 % of total Revenue
Life Science Member Sales Revenue Services Net    2.67 % of total Revenue

Q3 three months ended (Dec 31 2024)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
IRELAND 24.12 1.76 %
UNITED STATES 1,002.59 73.15 %
Other foreign locations 343.87 25.09 %
Healthcare 976.04 71.21 %
Healthcare Capital equipment revenues 254.80 18.59 %
Healthcare Consumable revenues 358.23 26.14 %
Healthcare Sales Revenue Services Net 363.01 26.49 %
Applied Sterilization Technologies 258.14 18.83 %
Applied Sterilization Technologies Capital equipment revenues 5.00 0.37 %
Applied Sterilization Technologies Sales Revenue Services Net 253.14 18.47 %
Life Science Member 136.38 9.95 %
Life Science Member Capital equipment revenues 31.06 2.27 %
Life Science Member Consumable revenues 68.68 5.01 %
Life Science Member Sales Revenue Services Net 36.64 2.67 %
Total 1,370.57 100 %




Q3 three months ended (Dec 31 2024)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
IRELAND 23.04 % -
UNITED STATES 5.54 % 2.35 %
Other foreign locations 4.78 % 5.29 %
Healthcare 6.53 % 3.37 %
Healthcare Capital equipment revenues -4.51 % 2.03 %
Healthcare Consumable revenues 8.74 % 4.84 %
Healthcare Sales Revenue Services Net 13.46 % 2.9 %
Applied Sterilization Technologies 9.88 % 0.55 %
Applied Sterilization Technologies Capital equipment revenues -4.52 % -43.17 %
Applied Sterilization Technologies Sales Revenue Services Net 10.21 % 2.1 %
Life Science Member -6.95 % 6.59 %
Life Science Member Capital equipment revenues -30.72 % 34.99 %
Life Science Member Consumable revenues 14.32 % -4.78 %
Life Science Member Sales Revenue Services Net -12.04 % 11.69 %
Total -1.8 % 3.13 %




Q3 three months ended (Dec 31 2024)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 173.29 12.64 %




Q3 three months ended (Dec 31 2024)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total 22.95 % 14.63 %




Annual Report on Steris Plc Divisions, Sales by Country

 
IRELAND   IRELAND Segment contribution to total sales 1.97 % of total Revenue
UNITED STATES   UNITED STATES Segment contribution to total sales 73.41 % of total Revenue
Other foreign locations   Other foreign locations Segment contribution to total sales 24.63 % of total Revenue
Healthcare   Healthcare Segment contribution to total sales 71.04 % of total Revenue
AST   AST Segment contribution to total sales 19.02 % of total Revenue
Life Sciences   Life Sciences Segment contribution to total sales 9.93 % of total Revenue
Healthcare Segment   Healthcare Segment Segment contribution to total sales 71.04 % of total Revenue
Capital equipment Healthcare Segment   Capital equipment Healthcare Segment Segment contribution to total sales 19 % of total Revenue
Capital equipment AST   Capital equipment AST Segment contribution to total sales 0.57 % of total Revenue
Capital equipment Life Sciences   Capital equipment Life Sciences Segment contribution to total sales 2.15 % of total Revenue
Consumables Healthcare Segment   Consumables Healthcare Segment Segment contribution to total sales 25.57 % of total Revenue
Consumables Life Sciences   Consumables Life Sciences Segment contribution to total sales 5.25 % of total Revenue
Service Healthcare Segment   Service Healthcare Segment Segment contribution to total sales 26.48 % of total Revenue
Service AST   Service AST Segment contribution to total sales 18.46 % of total Revenue
Service Life Sciences   Service Life Sciences Segment contribution to total sales 2.53 % of total Revenue


Twelve months ended 2025
STE s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
IRELAND 107.32 1.97 %
UNITED STATES 4,007.62 73.41 %
Other foreign locations 1,344.57 24.63 %
Healthcare 3,878.67 71.04 %
Total 5,459.52 100 %
AST 1,038.57 19.02 %
Life Sciences 542.27 9.93 %
Healthcare Segment 3,878.67 71.04 %
Capital equipment Healthcare Segment 1,037.20 19 %
Capital equipment AST 30.95 0.57 %
Capital equipment Life Sciences 117.53 2.15 %
Consumables Healthcare Segment 1,396.03 25.57 %
Consumables Life Sciences 286.66 5.25 %
Service Healthcare Segment 1,445.44 26.48 %
Service AST 1,007.63 18.46 %
Service Life Sciences 138.08 2.53 %


Twelve months ended 2025
STE s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 616.07 11.28 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
IRELAND 29.78 % -
UNITED STATES 6.83 % -
Other foreign locations 3.07 % -
Healthcare 7.35 % -
Total 6.24 % 62.09 %
AST 8.87 % -
Life Sciences -5.15 % -
Healthcare Segment 7.35 % -
Capital equipment Healthcare Segment -4.98 % -
Capital equipment AST 113.14 % -
Capital equipment Life Sciences -24.43 % -
Consumables Healthcare Segment 11.82 % -
Consumables Life Sciences 13.94 % -
Service Healthcare Segment 13.54 % -
Service AST 7.26 % -
Service Life Sciences -16.11 % -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com